TR199901692T2 - Formoterol i�eren yeni solunum form�lasyonu. - Google Patents

Formoterol i�eren yeni solunum form�lasyonu.

Info

Publication number
TR199901692T2
TR199901692T2 TR1999/01692T TR9901692T TR199901692T2 TR 199901692 T2 TR199901692 T2 TR 199901692T2 TR 1999/01692 T TR1999/01692 T TR 1999/01692T TR 9901692 T TR9901692 T TR 9901692T TR 199901692 T2 TR199901692 T2 TR 199901692T2
Authority
TR
Turkey
Prior art keywords
formulation containing
containing formoterol
new respiratory
respiratory formulation
formoterol
Prior art date
Application number
TR1999/01692T
Other languages
English (en)
Turkish (tr)
Inventor
Trofast Jan
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20405453&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR199901692(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of TR199901692T2 publication Critical patent/TR199901692T2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TR1999/01692T 1997-01-20 1998-01-13 Formoterol i�eren yeni solunum form�lasyonu. TR199901692T2 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9700134A SE9700134D0 (sv) 1997-01-20 1997-01-20 New formulation

Publications (1)

Publication Number Publication Date
TR199901692T2 true TR199901692T2 (xx) 1999-09-21

Family

ID=20405453

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/01692T TR199901692T2 (xx) 1997-01-20 1998-01-13 Formoterol i�eren yeni solunum form�lasyonu.

Country Status (32)

Country Link
EP (1) EP1009394B1 (cg-RX-API-DMAC10.html)
JP (2) JP4512203B2 (cg-RX-API-DMAC10.html)
KR (1) KR100528417B1 (cg-RX-API-DMAC10.html)
CN (1) CN1213741C (cg-RX-API-DMAC10.html)
AT (1) ATE257699T1 (cg-RX-API-DMAC10.html)
AU (1) AU728835B2 (cg-RX-API-DMAC10.html)
BE (1) BE1011401A3 (cg-RX-API-DMAC10.html)
BR (1) BR9806895A (cg-RX-API-DMAC10.html)
CA (1) CA2277890C (cg-RX-API-DMAC10.html)
CZ (1) CZ295682B6 (cg-RX-API-DMAC10.html)
DE (1) DE69821119T2 (cg-RX-API-DMAC10.html)
DK (1) DK1009394T3 (cg-RX-API-DMAC10.html)
EE (1) EE04038B1 (cg-RX-API-DMAC10.html)
ES (2) ES2212262T3 (cg-RX-API-DMAC10.html)
FR (1) FR2759907B1 (cg-RX-API-DMAC10.html)
GR (1) GR980100022A (cg-RX-API-DMAC10.html)
HU (1) HU228682B1 (cg-RX-API-DMAC10.html)
ID (1) ID21917A (cg-RX-API-DMAC10.html)
IE (1) IE980025A1 (cg-RX-API-DMAC10.html)
IL (1) IL130837A0 (cg-RX-API-DMAC10.html)
IS (1) IS2243B (cg-RX-API-DMAC10.html)
NL (1) NL1008021C2 (cg-RX-API-DMAC10.html)
NO (1) NO327457B1 (cg-RX-API-DMAC10.html)
NZ (1) NZ336593A (cg-RX-API-DMAC10.html)
PL (1) PL189552B1 (cg-RX-API-DMAC10.html)
PT (1) PT1009394E (cg-RX-API-DMAC10.html)
RU (1) RU2180220C2 (cg-RX-API-DMAC10.html)
SE (1) SE9700134D0 (cg-RX-API-DMAC10.html)
SK (1) SK283949B6 (cg-RX-API-DMAC10.html)
TR (1) TR199901692T2 (cg-RX-API-DMAC10.html)
UA (1) UA57763C2 (cg-RX-API-DMAC10.html)
WO (1) WO1998031351A1 (cg-RX-API-DMAC10.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9703407D0 (sv) 1997-09-19 1997-09-19 Astra Ab New use
SE9802073D0 (sv) 1998-06-11 1998-06-11 Astra Ab New use
ITMI991582A1 (it) 1999-07-16 2001-01-16 Chiesi Farma Spa Polveri costituite da particelle aventi la superficie perfettamente levigata da utilizzare come veicoli per la preparazione di miscele inala
GB9928311D0 (en) * 1999-11-30 2000-01-26 Novartis Ag Organic compounds
PE20011227A1 (es) 2000-04-17 2002-01-07 Chiesi Farma Spa Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
GB0009469D0 (en) 2000-04-17 2000-06-07 Vectura Ltd Improvements in or relating to formalities for use in inhaler devices
GB0012261D0 (en) * 2000-05-19 2000-07-12 Astrazeneca Ab Novel process
GB0012260D0 (en) 2000-05-19 2000-07-12 Astrazeneca Ab Novel composition
ITMI20010428A1 (it) * 2001-03-02 2002-09-02 Chemo Breath S A Composizioni ad uso inalatorio a base di formoterolo
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
SE0200657D0 (sv) * 2002-03-04 2002-03-04 Astrazeneca Ab Novel Formulation
GB0312148D0 (en) 2003-05-28 2003-07-02 Aventis Pharma Ltd Stabilized pharmaceutical products
GB0315889D0 (en) 2003-07-08 2003-08-13 Aventis Pharma Ltd Stable pharmaceutical products
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
DE102007049931A1 (de) 2007-10-18 2009-04-23 Pharmatech Gmbh Vorrichtung und Verfahren zur kontinuierlichen Herstellung von sphärischen Pulveragglomeraten
WO2011110852A1 (en) 2010-03-10 2011-09-15 Astrazeneca Ab Polymorphic forms of 6- [2- (4 -cyanophenyl) - 2h - pyrazol - 3 - yl] - 5 -methyl - 3 - oxo - 4 - (trifluoromethyl - phenyl) 3,4-dihydropyrazine-2-carboxylic acid ethylamide
EP2821062A1 (en) 2013-07-01 2015-01-07 Arven Ilac Sanayi Ve Ticaret A.S. Novel dry powder inhaler formulations
WO2015060743A1 (ru) * 2013-10-21 2015-04-30 Шолекс Девелопмент Гмбх Ингаляционный препарат для лечения болезней органов дыхания, содержащий в качестве активных веществ микронизированный салметерол ксинофоат и микронизированный флутиказона пропионат и способ его получения
MX2022003427A (es) 2019-09-24 2022-04-18 Chiesi Farm Spa Particulas portadoras novedosas para formulaciones de polvo seco para inhalacion.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3268533D1 (en) * 1981-07-24 1986-02-27 Fisons Plc Inhalation drugs, methods for their production and pharmaceutical formulations containing them
ATE17441T1 (de) * 1981-07-24 1986-02-15 Fisons Plc Inhalierbare arzneimittel, verfahren zu deren herstellung und pharmazeutische formulierungen diese enthaltend.
SE9302777D0 (sv) * 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
CA2123909C (en) * 1991-12-18 2002-10-01 Christer Carl Gustav Carling New combination of formoterol and budesonide
ES2166786T3 (es) * 1993-10-01 2002-05-01 Astrazeneca Ab Procedimiento i.
IS1736B (is) * 1993-10-01 1999-12-30 Astra Ab Aðferð og tæki sem stuðla að aukinni samloðun agna
SE9603669D0 (sv) * 1996-10-08 1996-10-08 Astra Ab New combination

Also Published As

Publication number Publication date
JP4512203B2 (ja) 2010-07-28
ES2149082A1 (es) 2000-10-16
BE1011401A3 (fr) 1999-08-03
DE69821119T2 (de) 2004-08-19
ID21917A (id) 1999-08-12
FR2759907B1 (fr) 2001-03-09
EP1009394A1 (en) 2000-06-21
CA2277890C (en) 2006-08-29
KR100528417B1 (ko) 2005-11-16
GR980100022A (el) 1998-09-30
AU5785898A (en) 1998-08-07
DE69821119D1 (de) 2004-02-19
HUP0000843A3 (en) 2000-10-30
UA57763C2 (uk) 2003-07-15
SK95899A3 (en) 2000-01-18
BR9806895A (pt) 2000-05-16
EE04038B1 (et) 2003-06-16
JP2010059180A (ja) 2010-03-18
JP2001508792A (ja) 2001-07-03
NO993538D0 (no) 1999-07-19
SK283949B6 (sk) 2004-05-04
NO993538L (no) 1999-09-17
AU728835B2 (en) 2001-01-18
NL1008021C2 (nl) 1998-10-07
IS2243B (is) 2007-05-15
RU2180220C2 (ru) 2002-03-10
CN1213741C (zh) 2005-08-10
KR20000070187A (ko) 2000-11-25
PL334528A1 (en) 2000-02-28
NZ336593A (en) 2001-01-26
PT1009394E (pt) 2004-05-31
CZ295682B6 (cs) 2005-09-14
CN1243435A (zh) 2000-02-02
NL1008021A1 (nl) 1998-07-22
ES2212262T3 (es) 2004-07-16
IS5109A (is) 1999-07-06
ATE257699T1 (de) 2004-01-15
NO327457B1 (no) 2009-07-06
CZ255699A3 (cs) 1999-10-13
SE9700134D0 (sv) 1997-01-20
HU228682B1 (en) 2013-05-28
EE9900294A (et) 2000-02-15
ES2149082B1 (es) 2001-05-16
PL189552B1 (pl) 2005-08-31
HUP0000843A2 (hu) 2000-09-28
IL130837A0 (en) 2001-01-28
IE980025A1 (en) 1998-10-07
DK1009394T3 (da) 2004-04-05
WO1998031351A1 (en) 1998-07-23
CA2277890A1 (en) 1998-07-23
FR2759907A1 (fr) 1998-08-28
EP1009394B1 (en) 2004-01-14

Similar Documents

Publication Publication Date Title
TR199901691T2 (xx) Budesonit i�eren yeni solunum form�lasyonu.
TR199901690T2 (xx) Yeni solunum form�lasyonu, form�lasyonu haz�rlamaya y�nelik i�lem.
SE9700134D0 (sv) New formulation
DK499181A (da) Hurtig-disintegrerende komprimerede laegemiddelpraeparater
TR199901689T2 (xx) Terb�talin s�lfat i�eren, yeni solunum form�lasyonu.
JPS5522687A (en) Novel drug containing benzene sulfone type compound as active substance*benzene sulfone type novel compound and their manufacture
FR2531960B1 (fr) Procede de preparation d'hydrolysats de keratine comportant, en greffage, des restes absorbeurs d'ultra-violets, hydrolysat correspondant et composition le contenant
NO810181L (no) Absorberende preparat for aa kontrollere fuktighet.